Kilitch Drugs (India) informs about disclosure

23 Apr 2022 Evaluate

Kilitch Drugs (India) has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavin Mukund Mehta.

The above information is a part of company’s filings submitted to BSE.

Kilitch Drugs(India) Share Price

351.30 3.40 (0.98%)
07-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1854.15
Dr. Reddys Lab 1350.75
Cipla 1497.80
Lupin 2357.65
Zydus Lifesciences 1001.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.